Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793878036> ?p ?o ?g. }
- W2793878036 endingPage "18" @default.
- W2793878036 startingPage "11" @default.
- W2793878036 abstract "Patients with neuroendocrine tumors expressing somatostatin receptors are often treated with 177Lu[Lu]-octreotate. Despite being highly effective in animal models, 177Lu[Lu]-octreotate-based therapies in the clinical setting can be optimized further. The aims of the study were to identify and elucidate possible optimization venues for 177Lu[Lu]-octreotate tumor therapy by characterizing transcriptional responses in the GOT1 small intestine neuroendocrine tumor model in nude mice. GOT1-bearing female BALB/c nude mice were intravenously injected with 15 MBq 177Lu[Lu]-octreotate (non-curative amount) or mock-treated with saline solution. Animals were killed 1, 3, 7 or 41 d after injection. Total RNA was extracted from the tumor samples and profiled using Illumina microarray expression analysis. Differentially expressed genes were identified (treated vs. control) and pathway analysis was performed. Distribution of differentially expressed transcripts indicated a time-dependent treatment response in GOT1 tumors after 177Lu[Lu]-octreotate administration. Regulation of CDKN1A, BCAT1 and PAM at 1 d after injection was compatible with growth arrest as the initial response to treatment. Upregulation of APOE and BAX at 3 d, and ADORA2A, BNIP3, BNIP3L and HSPB1 at 41 d after injection suggests first activation and then inhibition of the intrinsic apoptotic pathway during tumor regression and regrowth, respectively. Transcriptional analysis showed radiation-induced apoptosis as an early response after 177Lu[Lu]-octreotate administration, followed by pro-survival transcriptional changes in the tumor during the regrowth phase. Time-dependent changes in cell cycle and apoptosis-related processes suggest different time points after radionuclide therapy when tumor cells may be more susceptible to additional treatment, highlighting the importance of timing when administering multiple therapeutic agents." @default.
- W2793878036 created "2018-03-29" @default.
- W2793878036 creator A5007325991 @default.
- W2793878036 creator A5007655394 @default.
- W2793878036 creator A5015186131 @default.
- W2793878036 creator A5028017900 @default.
- W2793878036 creator A5047100959 @default.
- W2793878036 creator A5048819262 @default.
- W2793878036 creator A5056070577 @default.
- W2793878036 creator A5069898768 @default.
- W2793878036 creator A5081599526 @default.
- W2793878036 creator A5082149993 @default.
- W2793878036 date "2018-05-01" @default.
- W2793878036 modified "2023-10-14" @default.
- W2793878036 title "Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy" @default.
- W2793878036 cites W1434302077 @default.
- W2793878036 cites W1567631042 @default.
- W2793878036 cites W1900790478 @default.
- W2793878036 cites W1964719993 @default.
- W2793878036 cites W1970326135 @default.
- W2793878036 cites W1970679935 @default.
- W2793878036 cites W1980444527 @default.
- W2793878036 cites W1985144544 @default.
- W2793878036 cites W2018913523 @default.
- W2793878036 cites W2021678907 @default.
- W2793878036 cites W2028793063 @default.
- W2793878036 cites W2030082720 @default.
- W2793878036 cites W2032747682 @default.
- W2793878036 cites W2040459344 @default.
- W2793878036 cites W2060597630 @default.
- W2793878036 cites W2062504999 @default.
- W2793878036 cites W2067154401 @default.
- W2793878036 cites W2067274009 @default.
- W2793878036 cites W2074455613 @default.
- W2793878036 cites W2077814905 @default.
- W2793878036 cites W2090120574 @default.
- W2793878036 cites W2103017472 @default.
- W2793878036 cites W2109737973 @default.
- W2793878036 cites W2119921005 @default.
- W2793878036 cites W2121651045 @default.
- W2793878036 cites W2127350113 @default.
- W2793878036 cites W2134152344 @default.
- W2793878036 cites W2135736569 @default.
- W2793878036 cites W2137697949 @default.
- W2793878036 cites W2140828776 @default.
- W2793878036 cites W2151892353 @default.
- W2793878036 cites W2156258947 @default.
- W2793878036 cites W2161616089 @default.
- W2793878036 cites W2168301062 @default.
- W2793878036 cites W2171773667 @default.
- W2793878036 cites W2292620228 @default.
- W2793878036 cites W2332733549 @default.
- W2793878036 cites W2573369749 @default.
- W2793878036 cites W2575947145 @default.
- W2793878036 doi "https://doi.org/10.1016/j.nucmedbio.2018.01.006" @default.
- W2793878036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29502008" @default.
- W2793878036 hasPublicationYear "2018" @default.
- W2793878036 type Work @default.
- W2793878036 sameAs 2793878036 @default.
- W2793878036 citedByCount "7" @default.
- W2793878036 countsByYear W27938780362018 @default.
- W2793878036 countsByYear W27938780362019 @default.
- W2793878036 countsByYear W27938780362021 @default.
- W2793878036 countsByYear W27938780362022 @default.
- W2793878036 countsByYear W27938780362023 @default.
- W2793878036 crossrefType "journal-article" @default.
- W2793878036 hasAuthorship W2793878036A5007325991 @default.
- W2793878036 hasAuthorship W2793878036A5007655394 @default.
- W2793878036 hasAuthorship W2793878036A5015186131 @default.
- W2793878036 hasAuthorship W2793878036A5028017900 @default.
- W2793878036 hasAuthorship W2793878036A5047100959 @default.
- W2793878036 hasAuthorship W2793878036A5048819262 @default.
- W2793878036 hasAuthorship W2793878036A5056070577 @default.
- W2793878036 hasAuthorship W2793878036A5069898768 @default.
- W2793878036 hasAuthorship W2793878036A5081599526 @default.
- W2793878036 hasAuthorship W2793878036A5082149993 @default.
- W2793878036 hasBestOaLocation W27938780361 @default.
- W2793878036 hasConcept C104317684 @default.
- W2793878036 hasConcept C126322002 @default.
- W2793878036 hasConcept C127561419 @default.
- W2793878036 hasConcept C134018914 @default.
- W2793878036 hasConcept C185592680 @default.
- W2793878036 hasConcept C190283241 @default.
- W2793878036 hasConcept C2776297358 @default.
- W2793878036 hasConcept C2779066768 @default.
- W2793878036 hasConcept C2993559085 @default.
- W2793878036 hasConcept C502942594 @default.
- W2793878036 hasConcept C55493867 @default.
- W2793878036 hasConcept C71924100 @default.
- W2793878036 hasConcept C86803240 @default.
- W2793878036 hasConceptScore W2793878036C104317684 @default.
- W2793878036 hasConceptScore W2793878036C126322002 @default.
- W2793878036 hasConceptScore W2793878036C127561419 @default.
- W2793878036 hasConceptScore W2793878036C134018914 @default.
- W2793878036 hasConceptScore W2793878036C185592680 @default.
- W2793878036 hasConceptScore W2793878036C190283241 @default.
- W2793878036 hasConceptScore W2793878036C2776297358 @default.
- W2793878036 hasConceptScore W2793878036C2779066768 @default.